In this issue:
- Participation in a national cervical screening programme
- Minimally invasive vs open surgery hysterectomy for low-risk cervical cancer
- Survey of gynaecological brachytherapy practices in Australia and New Zealand
- Cemiplimab in recurrent cervical cancer
- Simlukafusp alfa in cervical squamous cell carcinoma
- DOACs vs LMWH for thromboprophylaxis
- Pembrolizumab in advanced or recurrent endometrial cancer
- Trastuzumab for advanced-stage HER2 overexpressing uterine cancer
- First-line lenvatinib + pembrolizumab for advanced endometrial cancer
- Preoperative imaging modalities in epithelial ovarian-tubal peritoneal cancer
Please login below to download this issue (PDF)